Chronic Lymphoblastic Leukemia

Chronic Lymphoblastic Leukemia (CLL) is a type of cancer that affects the bone marrow and blood cells. It is a disease that progresses slowly over time and is mostly seen in older adults. CLL is caused by the uncontrolled production of abnormal lymphocytes (a type of white blood cell) that do not function properly and eventually crowd out the normal cells in the bone marrow. This leads to a weakening of the body's immune system, increasing the risk of infections and other serious complications. Despite being a slow-progressing disease, CLL can be fatal if left untreated. This is why early detection and treatment are important. Hematologists and oncologists specialize in the diagnosis and treatment of CLL. They use a combination of chemotherapy, radiation therapy, and targeted drug therapy to manage the disease. Research continues to be conducted on CLL with the aim of improving available treatments and developing new ones. Advances in technology and genetics have allowed for a better understanding of the underlying mechanisms of the disease, leading to improved accuracy in diagnosis and prognosis. Clinical trials also offer promising avenues for finding better treatment options for CLL.